Canadian manufacturer of magic mushrooms and truffles Red Light Holland Corp. TRUFF‘s wholly-owned subsidiary, health tech company Radix Motion Inc.has received one International Preliminary Report on Patentability for his Patent application for the use of 3D motion data in psychedelic therapy.

“Red Light Holland continues to work with an outstanding team to protect our unique intellectual property aimed at increasing the benefits and responsible access to natural psilocybin,” said Todd Shapiro, CEO and director of Red Light.

The patent

With the patent first filed in July 2020 A USPTO examiner found that all seven claims contained in the application are novel and exhibit both inventive step and “industrial applicability” (utility).

See also: Free ketamine therapy? Laid-off tech workers can apply for the Freedom Month program

The examiner found that the claims were not previously made, which it renders admissible and eligible for the Fast Track exam under the Patent prosecution highway in the USA, Canada and other participating patent offices.

data as a key

Red Light CIO and Radix CEO Sarah Hashkes explained that the company aims to combine psychedelic usage data with technology that understands the human body and its movements to customize treatments and interventions to increase potential benefits also the use of “objective data for research and legalization efforts”.

Red Light’s patent advisor, Graham Pechenik shared his thrill of participating both companies’ “unique and ethical approach to patents, which respects user privacy and seeks to protect innovative technologies.”

See also: Psyched: Fed policies and research production quotas, Canada protests, Cal’s Decrim project

Pechenik believes the recent reviews by the USPTO examiner represent “a big step” towards a possible patent grant, as “The Opinion indicates that all procedural claims relating to psychedelic therapy are admissible as writtenand it suggests…